Clearance rates were 0–6.5% for placebo treatment, 76.6% for podophyllotoxin 0.15% cream administered for 4 weeks, 61.5% for podophyllotoxin 0.5% solution (2–6 weeks) and 53.7% for imiquimod 5 ...
In males, imiquimod treatment performed statistically significantly worse than the podophyllotoxin cream, with a 39% reduction in ITT clearance rate (only 42.7 vs 70.0% in podophyllotoxin cream ...